Cyril Mamotte

4.4k total citations · 1 hit paper
67 papers, 3.4k citations indexed

About

Cyril Mamotte is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cyril Mamotte has authored 67 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Surgery and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cyril Mamotte's work include Lipoproteins and Cardiovascular Health (9 papers), Immune Cell Function and Interaction (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Cyril Mamotte is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Immune Cell Function and Interaction (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Cyril Mamotte collaborates with scholars based in Australia, Canada and United States. Cyril Mamotte's co-authors include Frank M. van Bockxmeer, Roger R. Taylor, S. Mallal, David Nolan, Ian James, D. Sayer, A. Castley, Campbell S. Witt, Robin Williams and Donald M. Maxwell and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

Cyril Mamotte

67 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

2002 1.0k citations S. Mallal, David Nolan et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cyril Mamotte Australia	26	798	676	557	548	504	67	3.4k
Marie‐Anne Loriot France	44	1.3k 1.7×	349 0.5×	452 0.8×	329 0.6×	268 0.5×	159	5.8k
Patrick D. Walker United States	42	1.4k 1.8×	331 0.5×	538 1.0×	378 0.7×	306 0.6×	122	5.1k
Takashi Izumi Japan	41	1.6k 2.0×	492 0.7×	508 0.9×	1.5k 2.8×	487 1.0×	267	7.1k
John R. Sedor United States	44	2.2k 2.7×	326 0.5×	540 1.0×	754 1.4×	213 0.4×	150	6.2k
Marie J. Stuart United States	35	685 0.9×	535 0.8×	470 0.8×	861 1.6×	203 0.4×	127	4.7k
Masato Maekawa Japan	33	1.6k 2.0×	245 0.4×	486 0.9×	463 0.8×	188 0.4×	222	3.9k
Alexander J. Howie United Kingdom	40	1.4k 1.8×	186 0.3×	623 1.1×	576 1.1×	435 0.9×	132	5.8k
Akihiro Sekine Japan	31	1.5k 1.9×	151 0.2×	440 0.8×	325 0.6×	378 0.8×	103	4.4k
Masayoshi Soma Japan	34	1.4k 1.7×	346 0.5×	596 1.1×	543 1.0×	196 0.4×	256	4.6k
Michael M. Hoffmann Germany	39	1.1k 1.4×	169 0.3×	1.4k 2.5×	555 1.0×	171 0.3×	143	4.5k

Countries citing papers authored by Cyril Mamotte

Since Specialization

Citations

This map shows the geographic impact of Cyril Mamotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Mamotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Mamotte more than expected).

Fields of papers citing papers by Cyril Mamotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Mamotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Mamotte. The network helps show where Cyril Mamotte may publish in the future.

Co-authorship network of co-authors of Cyril Mamotte

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Mamotte. A scholar is included among the top collaborators of Cyril Mamotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Mamotte. Cyril Mamotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Helmerhorst, Erik, et al.. (2022). High-fat diet induced alterations in plasma membrane cholesterol content impairs insulin receptor binding and signalling in mouse liver but is ameliorated by atorvastatin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(6). 166372–166372. 6 indexed citations

Melton, Phillip E., et al.. (2020). Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome. Pharmacological Research. 160. 105174–105174. 98 indexed citations

Helmerhorst, Erik, et al.. (2019). Use of virus-like particles as a native membrane model to study the interaction of insulin with the insulin receptor. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1861(6). 1204–1212. 4 indexed citations

Jackaman, Connie, et al.. (2018). The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy. Frontiers in Medicine. 5. 337–337. 4 indexed citations

Carlessi, Rodrigo, Younan Chen, Jordan Rowlands, et al.. (2017). GLP-1 receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation. Scientific Reports. 7(1). 2661–2661. 95 indexed citations

Mamotte, Cyril, et al.. (2017). Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules. Ageing Research Reviews. 38. 40–51. 32 indexed citations

Carlessi, Rodrigo, Kevin N. Keane, Cyril Mamotte, & Philip Newsholme. (2017). Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?. European Journal of Clinical Nutrition. 71(7). 890–895. 11 indexed citations

Speers, David, et al.. (2014). Primary acute dengue and the deletion in chemokine receptor 5 (CCR5Δ32). Microbes and Infection. 16(6). 518–521. 6 indexed citations

Mullin, Benjamin H., Cyril Mamotte, Richard L. Prince, et al.. (2013). Conditional testing of multiple variants associated with bone mineral density in the FLNB gene region suggests that they represent a single association signal. BMC Genetics. 14(1). 107–107. 7 indexed citations

10.

Costantino, Paul, et al.. (2013). Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study. Infectious Agents and Cancer. 8(1). 33–33. 3 indexed citations

11.

Helmerhorst, Erik, et al.. (2012). Real-time and Label-free Bio-sensing of Molecular Interactions by Surface Plasmon Resonance: A Laboratory Medicine Perspective.. PubMed. 33(4). 161–73. 103 indexed citations

12.

Taylor, Roger R., et al.. (2007). LDL-Receptor mRNA Expression in Men Is Downregulated within an Hour of an Acute Fat Load and Is Influenced by Genetic Polymorphism , ,3. Journal of Nutrition. 137(9). 2062–2067. 13 indexed citations

13.

Hammond, E., Cyril Mamotte, David Nolan, & S. Mallal. (2007). HLA‐B*5701 typing: evaluation of an allele‐specific polymerase chain reaction melting assay. Tissue Antigens. 70(1). 58–61. 34 indexed citations

14.

Castley, A., et al.. (2003). Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy. AIDS. 17(1). 121–123. 1 indexed citations

15.

Thiry, Els, et al.. (2003). Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease. Atherosclerosis. 168(1). 115–121. 24 indexed citations

16.

Bilsborough, William, Daniel J. Green, Cyril Mamotte, et al.. (2003). Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function. Atherosclerosis. 169(1). 131–138. 26 indexed citations

17.

Mallal, S., David Nolan, Campbell S. Witt, et al.. (2002). Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. The Lancet. 359(9308). 727–732. 1001 indexed citations breakdown →

18.

Mamotte, Cyril, Valerie Burke, Roger R. Taylor, & Frank M. van Bockxmeer. (2002). Evidence of reduced coronary artery disease risk for apolipoprotein ϵ2/3 heterozygotes. European Journal of Internal Medicine. 13(4). 250–255. 11 indexed citations

19.

Taylor, Roger R., et al.. (2001). Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population. European Journal of Cardiovascular Prevention & Rehabilitation. 8(4). 235–241. 86 indexed citations

20.

Mamotte, Cyril, et al.. (1994). Apolipoprotein ε4 homozygosity — a determinant of restenosis after coronary angioplasty. Atherosclerosis. 110(2). 195–202. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact